Pallathadka Harikumar, Oghenemaro Enwa Felix, Saeed Bahaa Ibrahim, Esanmurodova N, R Roopashree, Nathiya Deepak, Kaur Parjinder, Kumar M Ravi, Kariem Muthena, H S Naher
Manipur International University, Imphal, Manipur, India.
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Delta State University, Abraka, Delta State, Nigeria.
Br J Nutr. 2025 Mar 28;133(6):817-826. doi: 10.1017/S0007114525000467. Epub 2025 Mar 7.
The therapeutic effects of soya consumption on adipokine concentrations have yielded inconsistent results in previous meta-analyses. This umbrella meta-analysis aims to investigate the impact of soya and its isoflavones on serum adiponectin and leptin levels in adults. We searched the Cochrane Central, Web of Science, PubMed and Scopus databases until October 10, 2024. The articles were restricted to those written in English. We included meta-analysis studies that evaluated the effects of soya and its isoflavones on levels of adiponectin and leptin and reported effect sizes (ES) and corresponding CI. Two independent reviewers screened all articles based on eligibility criteria and extracted the required data from the included meta-analyses. The meta-analysis was performed using a random-effects model in STATA software. Six meta-analyses of randomised controlled trials meeting the inclusion criteria were included in the current umbrella meta-analysis. The findings indicated that soya and its isoflavones did not have a significant effect on adiponectin (ES = 0·10; 95 % CI: −0·22, 0·41; = 0·55; = 51·8 %) and leptin (ES = −0·37; 95 % CI: −1·35, 0·61; = 0·46; = 71·2 %) concentrations. Subgroup analysis based on participants’ mean age, total sample size and duration was conducted. Results showed that the effect is not statistically significant in any of the subgroups. In conclusion, soya and its isoflavones could not improve the adipokines mentioned above. However, further high-quality research in different countries is required to substantiate these findings.
在以往的荟萃分析中,食用大豆对脂肪因子浓度的治疗效果产生了不一致的结果。本伞状荟萃分析旨在研究大豆及其异黄酮对成年人血清脂联素和瘦素水平的影响。我们检索了Cochrane Central、Web of Science、PubMed和Scopus数据库,直至2024年10月10日。文章仅限于用英文撰写的。我们纳入了评估大豆及其异黄酮对脂联素和瘦素水平的影响并报告效应量(ES)和相应置信区间(CI)的荟萃分析研究。两名独立评审员根据纳入标准筛选所有文章,并从纳入的荟萃分析中提取所需数据。荟萃分析使用STATA软件中的随机效应模型进行。本伞状荟萃分析纳入了六项符合纳入标准的随机对照试验的荟萃分析。研究结果表明,大豆及其异黄酮对脂联素(ES = 0·10;95% CI:−0·22,0·41;P = 0·55;I² = 51·8%)和瘦素(ES = −0·37;95% CI:−1·35,0·61;P = 0·46;I² = 71·2%)浓度没有显著影响。基于参与者的平均年龄、总样本量和持续时间进行了亚组分析。结果表明,在任何亚组中,效应均无统计学意义。总之,大豆及其异黄酮不能改善上述脂肪因子。然而,需要在不同国家进行进一步的高质量研究来证实这些发现。